Worth reading
47Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
47.8
% (year-on-year growth rate in operating profit)Wording
Conditional
How definitive the wording is.Results for this period
Third quarter1 January 2026–30 September 2026ConsolidatedJapanese GAAPNet Sales33,340¥ millionYear on year +21.1%Progress 71.9%
Operating profit2,381¥ millionYear on year +47.8%Progress 80.7%
Ordinary income3,097¥ millionYear on year +84.2%Progress 95.3%
Net income attributable to owners of the parent1,779¥ millionYear on year +59.7%Progress 98.8%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥58.81
Financial position at period-end
Total assets44,578¥ million
of which net assets 15,247 ¥ millionEquity ratio 34.2%vs. prior year-end -1.7pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Segment revenueHuman Resources Platform business ¥24,309 million (YoY +22.5%), Healthcare Platform Business ¥8,240 million (YoY +20.3%), New development services ¥791 million (YoY -7.0%)
Segment profitHuman Resources Platform business ¥8,120 million (YoY +19.3%), Healthcare Platform Business ¥-776 million, New development services ¥-578 million
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥46,400 million (YoY +26.1%)
Operating profit¥2,950 million (YoY +37.2%)
Ordinary income¥3,250 million (YoY +47.6%)
Net income¥1,800 million (YoY +84.5%)
Annual Dividend Forecast0 yen → 18 yen
Factors Behind Changes in Business Performance
In the Human Resources Platform Business, revenue increased due to growth in the number of customer business locations and worker members, as well as an increase in customer business locations for the online training system. In the Healthcare Platform Business, adoption of each product remained solid, increasing the number of medical institutions using the services. Growth investments, organisational strengthening, expansion of AI functions and consolidation of 株式会社ＲＭキャリア as a subsidiary were carried out.
Disclosure regarding the going concern assumption
None
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 1 company (株式会社ＲＭキャリア) / Excluded Not disclosed
Material subsequent eventsNone
Impairment lossNot applicable (material impairment loss relating to fixed assets)
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of property, plant and equipment ¥0 million / Extraordinary loss Loss on sale of non-current assets ¥0 million, Loss on disposal of fixed assets ¥2 million, Loss on step acquisitions ¥47 million
Depreciation and amortization¥835 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingYes (for institutional investors and analysts)
Issued Shares at Period-End31,808,600 shares
Treasury Shares at Period-End1,585,057 treasury shares
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–30 September 2026 |
| Net Sales | ¥33,340 million (YoY +21.1%) |
| Operating profit | ¥2,381 million (YoY +47.8%) |
| Ordinary income | ¥3,097 million (YoY +84.2%) |
| Profit attributable to owners of the parent | ¥1,779 million (YoY +59.7%) |
| Net income per share | ¥58.81 |
| Equity ratio | End of the current fiscal period 34.2 / End of previous period 35.9 |
| Total assets | ¥44,578 million |
| Net assets | ¥15,247 million |
| Full-year earnings forecast | Net Sales ¥46,400 million (YoY +26.1%) / Operating profit ¥2,950 million (YoY +37.2%) / Ordinary income ¥3,250 million (YoY +47.6%) / Net income ¥1,800 million (YoY +84.5%) |
| Annual Dividend Forecast | 0 yen → 18 yen |
| Segment revenue | Human Resources Platform business ¥24,309 million (YoY +22.5%), Healthcare Platform Business ¥8,240 million (YoY +20.3%), New development services ¥791 million (YoY -7.0%) |
| Segment profit | Human Resources Platform business ¥8,120 million (YoY +19.3%), Healthcare Platform Business ¥-776 million, New development services ¥-578 million |
| Depreciation and amortization | ¥835 million |
| Impairment loss | Not applicable (material impairment loss relating to fixed assets) |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of property, plant and equipment ¥0 million / Extraordinary loss Loss on sale of non-current assets ¥0 million, Loss on disposal of fixed assets ¥2 million, Loss on step acquisitions ¥47 million |
| Disclosure regarding the going concern assumption | None |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 1 company (株式会社ＲＭキャリア) / Excluded Not disclosed |
| Material subsequent events | None |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Yes (for institutional investors and analysts) |
| Issued Shares at Period-End | 31,808,600 shares |
| Treasury Shares at Period-End | 1,585,057 treasury shares |
| Factors Behind Changes in Business Performance | In the Human Resources Platform Business, revenue increased due to growth in the number of customer business locations and worker members, as well as an increase in customer business locations for the online training system. In the Healthcare Platform Business, adoption of each product remained solid, increasing the number of medical institutions using the services. Growth investments, organisational strengthening, expansion of AI functions and consolidation of 株式会社ＲＭキャリア as a subsidiary were carried out. |
Items this document does not state (10)
Operating MarginCash flows from operating activitiesCash flows from investing activitiesCash flows from financing activitiesCash and cash equivalents at end of periodRevision to Earnings ForecastPayout ratioShareholder Return PolicyRegional salesOrders received and order backlog
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue increased as the number of customer business locations, worker members and medical institutions using the services grew, along with expanded adoption of each product. The company also advanced its marketing activities, growth investments, organisational strengthening, expansion of AI functions and consolidation of 株式会社ＲＭキャリア as a subsidiary.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.